Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Efemoral Medical
Los Altos, California, United Statesefemoralmedical.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Efemoral Medical’s lead product, the Efemoral Vascular Scaffold System (EVSS), has demonstrated promising early results in first-in-human studies. The EVSS achieved 0% post-procedure residual stenosis—the lowest ever reported for a femoropopliteal trial—and maintained a mean minimal lumen diameter of 4.74 mm at six months, the highest reported to date. The system aims to provide durable outcomes without permanent implants and has received FDA Breakthrough Device designation for treating chronic limb-threatening ischemia.
- Therapeutic areas
- Cardiovascular
- Modalities
- DeviceBioresorbable scaffoldDrug-eluting scaffold
- Industry
- Implantable Medical Devices
Beyond the preview
Go deeper on Efemoral Medical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Efemoral Medical.